Tag | Content |
---|
EnhancerAtlas ID | HS109-14864 |
Organism | Homo sapiens |
Tissue/cell | Kasumi-1 |
Coordinate | chr3:4909270-4911290 |
SNPs | Number: 1 | ID | Chromosome | Position | Genome Version |
|
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
IRF1 | MA0050.2 | chr3:4911198-4911219 | TCTTTCTTTCTTTTTTTTTTT | + | 6.25 | KLF16 | MA0741.1 | chr3:4910267-4910278 | GCCCCGCCCCC | + | 6.02 | KLF5 | MA0599.1 | chr3:4910267-4910277 | GCCCCGCCCC | + | 6.02 | NRF1 | MA0506.1 | chr3:4910169-4910180 | GCGCCTGCGCG | + | 6.14 | SP4 | MA0685.1 | chr3:4910264-4910281 | ATCGCCCCGCCCCCTCC | + | 6 |
|
| Number of super-enhancer constituents: 4 | ID | Coordinate | Tissue/cell |
SE_18602 | chr3:4908063-4912293 | CD4p_CD25-_Il17-_PMAstim_Th | SE_19590 | chr3:4908204-4911214 | CD4p_CD25-_Il17p_PMAstim_Th17 | SE_20241 | chr3:4907902-4911210 | CD56 | SE_49889 | chr3:4905767-4910143 | RPMI-8402 |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 2 | Chromosome | Start | End |
chr3 | 4909917 | 4910799 | chr3 | 4910393 | 4911000 |
|
| Number: 1 | ID | Chromosome | Start | End |
GH03I004866 | chr3 | 4907845 | 4911822 |
|
Enhancer Sequence | AACACTAAAC TAGAAAGATG TGCAAAGTAA GACTGAGCAG CTTTTTCTAC GGCAGGGATC 60 AATGGGAGTG TACGTAATAA ATGAATAATT GCATTCCTTC TCCCTGGCCA GCCGACAGAG 120 TGGAAATCGA CCTCTGTTCG GCGGGCATGC ACAACCGGCT GGCATGGTGT CTGCGTTCCC 180 CTCCTATGAA AGGATCAGCT CTAGTTACAT GCCCTGTGCG CGGCCTGAAG CCTGTAACCG 240 GGATTACGAG CCCACTATGA GCCAGGGACT AAAGGTGACA CAGATTTCAC CTCTTTTCAT 300 TACCTTTGAA GGAAGTTCTG TGCCCTGACG AGGAAACTGG GGCCAAGCTC GCATAGGCAG 360 TGCGGCCGAG TCAGCCCTGT GGCCCCCAAG CTGGGGCACG AACCCACCGC AGTGCTTGCA 420 CCAGGCACTG GCTCCGAGAG CAAAGGCATG ACTGGGCACC TAAATACCCA CTAGGCAGGC 480 AGTGACTGCG ACAGTAACTC TCTTCTTTTT GGCCACTCTC AGGCCGCAAG TCCTCCAGAA 540 AACGGAAAAC TGAGGCGCGA GCCAAGTCAC TTTCCAAAGG TCACAGCTGG TAGCAGGCCG 600 AGGAGGGCCT CCAGGCCTGG TGCTTGCGAC CCTCAACGAC CATCTGTAAT AATGCCCAGA 660 GCCTCTGCCA GGATTCCCCA GCCCTATGTT CCCGCGGCCT TTGAGGGGAA AGGGCCAGGG 720 CCTAGACGTT CCCCTCCCGC GTGGTTTTCC CGTCAGCAGC TTTCGTCTGC AAGGGAAAGC 780 GGCGGCCCCA CCCGCAGACA GCTGCGAGGC ACCGCGCCAA GCGTATGCGC CTGTTCCCAG 840 GCACTCCCTC CTCCGCCTTC ACCCTTTTGC CACCTCCGCC CTCCACCCAG CCCCGCCGTG 900 CGCCTGCGCG CCCCGGCCCG TGGGCCAGCG GGCAGTCTAC TCACGTGGGC CTCCGCATGG 960 CCCAGCGCCG CCAAGGGCAA GGCGGAGCCT CGCGATCGCC CCGCCCCCTC CGTGCCCCGC 1020 CTCCTGTAGG GAGCGCGGGA CCCTCGGCTG GCGCGGGCAC TTCCCAGCCC AGCCCGGGGC 1080 GCCGGCTTCG CCGCGTGCGC GTGCGCATGG TGGGGTTTGG CTGGCTGCGG GATGCGGTCG 1140 AGGCCGCCGA GGCCGCAAAC TCCAGTGGGA AGGCGGCGTG CCGCGGCCGG CTTCGGTGGA 1200 GGAGGGGGCG TTTCCCCGGA AAAGGAAGGA AGTGGGTGTC ACGGGCCTCA ATACGGCCCC 1260 TTTGACGTCT TGAGTGGGAA ATCACAAGAT ACTGCTCCAG ATTTTCCCAT TTTATGGCTA 1320 AATCCAAATG ACTCGGACCC CCTGCCCCAT CACATCAGGA ACTTCAGCAG TTCCTTCCAC 1380 CAAAGCTCAA CTATTGCTGC AAGCGCTTTG GTAATCACGA GCATTATCTA TGAAGCTACT 1440 GCTGTGGTCA GGGCCCCAGT CGTCCTGCTG AGTAGCAGAC TTTGAAAGAC GGTGTCCAAG 1500 GCCACCCTGC TGGTCAGTGA CCTGCTCTAG AGGCTAAGCC AGGGCATGCT TAGAACTTTG 1560 ATATTTAGAC TTCTTACATT AACTTAACCC AGTTAACAGG TTTGTGGGGG CATTTTTTGT 1620 TTGTTTTTTT GAGACCGAGT CTCGCTGTGT CACCCAGGCT GGAGTGCAGT GGCACAATCT 1680 CTGCTCACTG CAGCTTCTGC CTCCCGGATT CAAGCAATTC TCTCACCTCA GCCTCCAGAG 1740 TAGCTGGGAT TAGACGTGTG CCACCACACC CAGCTAATTT TTGTATTTTT AGTAGAGACA 1800 GGATTTCACC ATGTTGTCCA GGCTGGTCTC GAACTCCTGG CCTCAAGTGA TATACCCGCC 1860 CGGCCTCGCA AAGTGCTGGG ATTACAGGCG TTAGCCACCG CACCTGGCCT TGTGGGTTTT 1920 TTTTTCTTTC TTTCTTTCTT TTTTTTTTTT TTTTTTTTTT TTTAAGAGAC AGGATATTGC 1980 TGTATTGCCC AGGCTGGAGT GCAGTGGCAT GATCATAGCT 2020
|